{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T09:58:36Z","timestamp":1794650316989,"version":"4.9.1"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T00:00:00Z","timestamp":1727654400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004167","name":"Medicines for Malaria Venture","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004167","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.ejmech.2024.116921","type":"journal-article","created":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T06:11:19Z","timestamp":1727935879000},"page":"116921","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Exploration and characterization of the antimalarial activity of cyclopropyl carboxamides that target the mitochondrial protein, cytochrome b"],"prefix":"10.1016","volume":"280","author":[{"given":"Jon Kyle","family":"Awalt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyin","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Loi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate E.","family":"Jarman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jocelyn S.","family":"Penington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saishyam","family":"Ramesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate J.","family":"Fairhurst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Yeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heekuk","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Catrin","family":"Uhlemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bikash","family":"Chandra Maity","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirupam","family":"De","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Partha","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnish","family":"Chakraborty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alisje","family":"Churchyard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mufuliat T.","family":"Famodimu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Delves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jake","family":"Baum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nimisha","family":"Mittal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Winzeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony T.","family":"Papenfuss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mrittika","family":"Chowdury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania F.","family":"de Koning-Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander G.","family":"Maier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giel G.","family":"van Dooren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Baud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Brand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Fidock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul F.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan F.","family":"Cowman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeline G.","family":"Dans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9117-1048","authenticated-orcid":false,"given":"Brad E.","family":"Sleebs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2024.116921_bib1","series-title":"World Malaria Report","year":"2022"},{"issue":"1","key":"10.1016\/j.ejmech.2024.116921_bib2","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12936-016-1675-x","article-title":"New developments in anti-malarial target candidate and product profiles","volume":"16","author":"Burrows","year":"2017","journal-title":"Malar. J."},{"issue":"5","key":"10.1016\/j.ejmech.2024.116921_bib3","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMoa1314981","article-title":"Spread of artemisinin resistance in Plasmodium falciparum malaria","volume":"371","author":"Ashley","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.ejmech.2024.116921_bib4","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1038\/s41591-020-1005-2","article-title":"Emergence and clonal expansion of in vitro artemisinin-resistant Plasmodium falciparum kelch13 R561H mutant parasites in Rwanda","volume":"26","author":"Uwimana","year":"2020","journal-title":"Nat. Med."},{"issue":"23","key":"10.1016\/j.ejmech.2024.116921_bib5","doi-asserted-by":"crossref","first-page":"10526","DOI":"10.1021\/acs.jmedchem.9b00761","article-title":"The development process for discovery and clinical advancement of modern antimalarials","volume":"62","author":"Ashton","year":"2019","journal-title":"J. Med. Chem."},{"issue":"6","key":"10.1016\/j.ejmech.2024.116921_bib6","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/S1473-3099(17)30171-8","article-title":"Safety, tolerability, pharmacokinetics, and activity of the novel long-acting antimalarial DSM265: a two-part first-in-human phase 1a\/1b randomised study","volume":"17","author":"McCarthy","year":"2017","journal-title":"Lancet Infect. Dis."},{"issue":"10","key":"10.1016\/j.ejmech.2024.116921_bib7","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1093\/cid\/ciab716","article-title":"Efficacy of cipargamin (KAE609) in a randomized, phase II dose-escalation study in adults in sub-Saharan Africa with uncomplicated Plasmodium falciparum malaria","volume":"74","author":"Schmitt","year":"2022","journal-title":"Clin. Infect. Dis."},{"issue":"3","key":"10.1016\/j.ejmech.2024.116921_bib8","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1021\/acsinfecdis.2c00607","article-title":"7-N-Substituted-3-oxadiazole quinolones with potent antimalarial activity target the cytochrome bc(1) complex","volume":"9","author":"Nguyen","year":"2023","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ejmech.2024.116921_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105244","article-title":"Optimisation of 2-(N-phenyl carboxamide) triazolopyrimidine antimalarials with moderate to slow acting erythrocytic stage activity","volume":"115","author":"Bailey","year":"2021","journal-title":"Bioorg. Chem."},{"issue":"5","key":"10.1016\/j.ejmech.2024.116921_bib10","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1021\/acs.jmedchem.2c02092","article-title":"Optimization of 2,3-dihydroquinazolinone-3-carboxamides as antimalarials targeting PfATP4","volume":"66","author":"Ashton","year":"2023","journal-title":"J. Med. Chem."},{"issue":"16","key":"10.1016\/j.ejmech.2024.116921_bib11","doi-asserted-by":"crossref","first-page":"14493","DOI":"10.1021\/acs.jmedchem.4c01241","article-title":"Property and activity refinement of dihydroquinazolinone-3-carboxamides as orally efficacious antimalarials that target PfATP4","volume":"67","author":"Ashton","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116921_bib12","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202400549","article-title":"Lactam truncation yields a dihydroquinazolinone scaffold with potent antimalarial activity that targets PfATP4","author":"Ashton","year":"2024","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2024.116921_bib13","doi-asserted-by":"crossref","first-page":"5219","DOI":"10.1038\/s41467-024-49491-8","article-title":"Aryl amino acetamides prevent the development of Plasmodium falciparum rings via targeting the lipid transfer protein PfSTART1","volume":"15","author":"Dans","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2024.116921_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116354","article-title":"Activity refinement of aryl amino acetamides that target the P. falciparum STAR-related lipid transfer 1 protein","volume":"270","author":"Nguyen","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116921_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116677","article-title":"Optimization of pyrazolopyridine 4-carboxamides with potent antimalarial activity that is resistant to the P. falciparum transporter ABCI3","volume":"276","author":"Calic","year":"2024","journal-title":"Eur. J. Med. Chem."},{"issue":"6419","key":"10.1016\/j.ejmech.2024.116921_bib16","doi-asserted-by":"crossref","DOI":"10.1126\/science.aat9446","article-title":"Open-source discovery of chemical leads for next-generation chemoprotective antimalarials","volume":"362","author":"Antonova-Koch","year":"2018","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.ejmech.2024.116921_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1011517","article-title":"A screen of drug-like molecules identifies chemically diverse electron transport chain inhibitors in apicomplexan parasites","volume":"19","author":"Hayward","year":"2023","journal-title":"PLoS Pathog."},{"issue":"7131","key":"10.1016\/j.ejmech.2024.116921_bib18","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nature05572","article-title":"Specific role of mitochondrial electron transport in blood-stage Plasmodium falciparum","volume":"446","author":"Painter","year":"2007","journal-title":"Nature"},{"issue":"296","key":"10.1016\/j.ejmech.2024.116921_bib19","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaa6645","article-title":"A long-duration dihydroorotate dehydrogenase inhibitor (DSM265) for prevention and treatment of malaria","volume":"7","author":"Phillips","year":"2015","journal-title":"Sci. Transl. Med."},{"issue":"13","key":"10.1016\/j.ejmech.2024.116921_bib20","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.4155\/fmc.13.121","article-title":"Targeting the mitochondrial electron transport chain of Plasmodium falciparum: new strategies towards the development of improved antimalarials for the elimination era","volume":"5","author":"Nixon","year":"2013","journal-title":"Future Med. Chem."},{"issue":"6","key":"10.1016\/j.ejmech.2024.116921_bib21","doi-asserted-by":"crossref","first-page":"597","DOI":"10.2165\/00003495-200363060-00006","article-title":"Atovaquone\/proguanil: a review of its use for the prophylaxis of Plasmodium falciparum malaria","volume":"63","author":"McKeage","year":"2003","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.ejmech.2024.116921_bib22","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.1038\/ncomms5029","article-title":"Structural analysis of atovaquone-inhibited cytochrome bc1 complex reveals the molecular basis of antimalarial drug action","volume":"5","author":"Birth","year":"2014","journal-title":"Nat. Commun."},{"issue":"177","key":"10.1016\/j.ejmech.2024.116921_bib23","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3005029","article-title":"Quinolone-3-diarylethers: a new class of antimalarial drug","volume":"5","author":"Nilsen","year":"2013","journal-title":"Sci. Transl. Med."},{"issue":"3","key":"10.1016\/j.ejmech.2024.116921_bib24","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02143-20","article-title":"Atypical molecular basis for drug resistance to mitochondrial function inhibitors in Plasmodium falciparum","volume":"65","author":"Painter","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.ejmech.2024.116921_bib25","doi-asserted-by":"crossref","first-page":"P81","DOI":"10.1186\/1475-2875-13-S1-P81","article-title":"Molecular basis of extreme resistance in Plasmodium falciparum to atovaquone and other mitochondrial inhibitors","volume":"13","author":"Siegel","year":"2014","journal-title":"Malar. J."},{"issue":"3","key":"10.1016\/j.ejmech.2024.116921_bib26","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1021\/acs.jmedchem.6b01673","article-title":"Optimization of 2-anilino 4-amino substituted quinazolines into potent antimalarial agents with oral in vivo activity","volume":"60","author":"Gilson","year":"2017","journal-title":"J. Med. Chem."},{"issue":"10","key":"10.1016\/j.ejmech.2024.116921_bib27","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1021\/ja054938+","article-title":"Cytochrome P450-catalyzed oxidation of N-benzyl-N-cyclopropylamine generates both cyclopropanone hydrate and 3-hydroxypropionaldehyde via hydrogen Abstraction, not single electron transfer","volume":"128","author":"Cerny","year":"2006","journal-title":"J. Am. Chem. Soc."},{"issue":"6677","key":"10.1016\/j.ejmech.2024.116921_bib28","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/33612","article-title":"Electron transfer by domain movement in cytochrome bc1","volume":"392","author":"Zhang","year":"1998","journal-title":"Nature"},{"issue":"24","key":"10.1016\/j.ejmech.2024.116921_bib29","doi-asserted-by":"crossref","first-page":"6285","DOI":"10.1073\/pnas.1804492115","article-title":"Selection of Plasmodium falciparum cytochrome B mutants by putative PfNDH2 inhibitors","volume":"115","author":"Lane","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"11","key":"10.1016\/j.ejmech.2024.116921_bib30","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1021\/cb200105d","article-title":"A chemical genomic analysis of decoquinate, a Plasmodium falciparum cytochrome b inhibitor","volume":"6","author":"Nam","year":"2011","journal-title":"ACS Chem. Biol."},{"issue":"12","key":"10.1016\/j.ejmech.2024.116921_bib31","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/j.chembiol.2011.09.016","article-title":"Identification and validation of tetracyclic benzothiazepines as Plasmodium falciparum cytochrome bc1 inhibitors","volume":"18","author":"Dong","year":"2011","journal-title":"Chem. Biol."},{"issue":"3","key":"10.1016\/j.ejmech.2024.116921_bib32","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1073\/pnas.1416611112","article-title":"Antimalarial 4(1H)-pyridones bind to the Qi site of cytochrome bc1","volume":"112","author":"Capper","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"1","key":"10.1016\/j.ejmech.2024.116921_bib33","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1186\/1475-2875-11-292","article-title":"A framework for assessing the risk of resistance for anti-malarials in development","volume":"11","author":"Ding","year":"2012","journal-title":"Malar. J."},{"issue":"1","key":"10.1016\/j.ejmech.2024.116921_bib34","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1038\/s41467-023-38774-1","article-title":"Generation of a mutator parasite to drive resistome discovery in Plasmodium falciparum","volume":"14","author":"K\u00fcmpornsin","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2024.116921_bib35","doi-asserted-by":"crossref","DOI":"10.1093\/femsle\/fnad050","article-title":"Plasmodium falciparum COQ2 gene encodes a functional 4-hydroxybenzoate polyprenyltransferase","volume":"370","author":"Zafra","year":"2023","journal-title":"FEMS Microbiol. Lett."},{"key":"10.1016\/j.ejmech.2024.116921_bib36","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.ijbiomac.2016.12.033","article-title":"Characterization of 4-hydroxy-3-methylbut-2-en-1-yl diphosphate synthase (IspG) from Plasmodium vivax and it's potential as an antimalarial drug target","volume":"96","author":"Saggu","year":"2017","journal-title":"Int. J. Biol. Macromol."},{"issue":"4","key":"10.1016\/j.ejmech.2024.116921_bib37","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1128\/AAC.04149-14","article-title":"Subtle changes in endochin-like quinolone structure alter the site of inhibition within the cytochrome bc1 complex of Plasmodium falciparum","volume":"59","author":"Stickles","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"10.1016\/j.ejmech.2024.116921_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0030949","article-title":"P. falciparum in vitro killing rates allow to discriminate between different antimalarial mode-of-action","volume":"7","author":"Sanz","year":"2012","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.ejmech.2024.116921_bib39","doi-asserted-by":"crossref","first-page":"4333","DOI":"10.1128\/AAC.01685-15","article-title":"In vitro analysis of the interaction between atovaquone and proguanil against liver stage malaria parasites","volume":"60","author":"Barata","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"issue":"3","key":"10.1016\/j.ejmech.2024.116921_bib40","doi-asserted-by":"crossref","first-page":"452","DOI":"10.2307\/3283831","article-title":"Inhibitory activity of the anti-malarial atovaquone (566C80) against ookinetes, oocysts, and sporozoites of Plasmodium berghei","volume":"81","author":"Fowler","year":"1995","journal-title":"J. Parasitol."},{"issue":"12","key":"10.1016\/j.ejmech.2024.116921_bib41","doi-asserted-by":"crossref","first-page":"7292","DOI":"10.1128\/AAC.03666-14","article-title":"A male and female gametocyte functional viability assay to identify biologically relevant malaria transmission-blocking drugs","volume":"58","author":"Ruecker","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"issue":"4","key":"10.1016\/j.ejmech.2024.116921_bib42","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1021\/acsinfecdis.5b00143","article-title":"High-throughput luciferase-based assay for the discovery of therapeutics that prevent malaria","volume":"2","author":"Swann","year":"2016","journal-title":"ACS Infect. Dis."},{"issue":"1","key":"10.1016\/j.ejmech.2024.116921_bib43","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.molbiopara.2004.04.007","article-title":"A Plasmodium berghei reference line that constitutively expresses GFP at a high level throughout the complete life cycle","volume":"137","author":"Franke-Fayard","year":"2004","journal-title":"Mol. Biochem. Parasitol."},{"issue":"14","key":"10.1016\/j.ejmech.2024.116921_bib44","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.2174\/1568026614666140808124638","article-title":"4(1H)-pyridone and 4(1H)-quinolone derivatives as antimalarials with erythrocytic, exoerythrocytic, and transmission blocking activities","volume":"14","author":"Monastyrskyi","year":"2014","journal-title":"Curr. Top. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2024.116921_bib45","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1128\/AAC.00793-12","article-title":"4(1H)-Quinolones with liver stage activity against Plasmodium berghei","volume":"57","author":"LaCrue Alexis","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.ejmech.2024.116921_bib46","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1128\/EC.00267-08","article-title":"Apicoplast and mitochondrion in gametocytogenesis of Plasmodium falciparum","volume":"8","author":"Okamoto","year":"2009","journal-title":"Eukaryot. Cell"},{"issue":"1","key":"10.1016\/j.ejmech.2024.116921_bib47","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.celrep.2015.03.011","article-title":"Genetic investigation of tricarboxylic acid metabolism during the Plasmodium falciparum life cycle","volume":"11","author":"Ke","year":"2015","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.ejmech.2024.116921_bib48","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1186\/1475-2875-13-315","article-title":"Proteomic analysis of the Plasmodium male gamete reveals the key role for glycolysis in flagellar motility","volume":"13","author":"Talman","year":"2014","journal-title":"Malar. J."},{"issue":"3","key":"10.1016\/j.ejmech.2024.116921_bib49","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01804-18","article-title":"Evaluation of 4-amino 2-anilinoquinazolines against Plasmodium and Other Apicomplexan parasites in vitro and in a P. falciparum humanized NOD-scid IL2R\u03b3(null) mouse model of malaria","volume":"63","author":"Gilson","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2024.116921_bib50","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ejmech.2018.05.022","article-title":"Enhanced antimalarial activity of plasmepsin V inhibitors by modification of the P(2) position of PEXEL peptidomimetics","volume":"154","author":"Nguyen","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116921_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105359","article-title":"Property activity refinement of 2-anilino 4-amino substituted quinazolines as antimalarials with fast acting asexual parasite activity","volume":"117","author":"Ashton","year":"2021","journal-title":"Bioorg. Chem."},{"issue":"W1","key":"10.1016\/j.ejmech.2024.116921_bib52","doi-asserted-by":"crossref","first-page":"W296","DOI":"10.1093\/nar\/gky427","article-title":"SWISS-MODEL: homology modelling of protein structures and complexes","volume":"46","author":"Waterhouse","year":"2018","journal-title":"Nucleic Acids Res."},{"issue":"8","key":"10.1016\/j.ejmech.2024.116921_bib53","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1093\/infdis\/jis184","article-title":"Drug screen targeted at Plasmodium liver stages identifies a potent multistage antimalarial drug","volume":"205","author":"da Cruz","year":"2012","journal-title":"J. Infect. Dis."},{"issue":"2","key":"10.1016\/j.ejmech.2024.116921_bib54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000010","article-title":"Hepatocyte permissiveness to Plasmodium infection is conveyed by a short and structurally conserved region of the CD81 large extracellular domain","volume":"4","author":"Yalaoui","year":"2008","journal-title":"PLoS Pathog."},{"issue":"9","key":"10.1016\/j.ejmech.2024.116921_bib55","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1038\/nprot.2016.096","article-title":"Routine in vitro culture of P. falciparum gametocytes to evaluate novel transmission-blocking interventions","volume":"11","author":"Delves","year":"2016","journal-title":"Nat. Protoc."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352342400802X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352342400802X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T06:22:08Z","timestamp":1732170128000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S022352342400802X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":55,"alternative-id":["S022352342400802X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116921","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploration and characterization of the antimalarial activity of cyclopropyl carboxamides that target the mitochondrial protein, cytochrome b","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116921","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"116921"}}